This was characterized by increased CD8+ cytotoxic T lymphocytes, CD20+ B lymphocytes, and tumor-suppressive (CD11c+) macrophages, along with a decrease in tumor-promoting (CD163+) macrophages. The gene discussed is ITGAX; the disease is neoplasm.